These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Concerning the viewpoint; "An anti-doping sampling strategy utilizing the sewerage systems of sport villages". Harman C; Reid M; Thomas KV Environ Sci Technol; 2011 May; 45(10):4191; author reply 4192. PubMed ID: 21500825 [No Abstract] [Full Text] [Related]
30. [Medication, athletes and doping regulations]. Hartgens F Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164 [TBL] [Abstract][Full Text] [Related]
31. Doping in the recombinant era: strategies and counterstrategies. Azzazy HM; Mansour MM; Christenson RH Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094 [TBL] [Abstract][Full Text] [Related]
32. The faking of champions. DeFrancesco L Nat Biotechnol; 2004 Sep; 22(9):1069-71. PubMed ID: 15340461 [No Abstract] [Full Text] [Related]
33. Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. Van Renterghem P; Van Eenoo P; Van Thuyne W; Geyer H; Schänzer W; Delbeke FT J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):225-35. PubMed ID: 19010743 [TBL] [Abstract][Full Text] [Related]
34. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite. Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080 [TBL] [Abstract][Full Text] [Related]
35. Drug testing. Uzych L Nature; 1994 Nov; 372(6501):10. PubMed ID: 7818709 [No Abstract] [Full Text] [Related]
37. Mass spectrometric determination of insulins and their degradation products in sports drug testing. Thevis M; Thomas A; Schänzer W Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882 [TBL] [Abstract][Full Text] [Related]